Business Context and Reporting Period
Company: Archimedes Tech SPAC Partners III Co.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2026
Status: Blank check company (SPAC) incorporated in the Cayman Islands on August 1, 2025. The company has not commenced operations and is focused on identifying a target for a business combination in the technology industry.
Key Event: The company consummated its Initial Public Offering (IPO) on January 26, 2026, selling 27,600,000 Units (including full over-allotment exercise) and 762,000 Private Placement Units.
Key Financial Metrics
| Metric | Value (as of/for period ended March 31, 2026) |
|---|---|
| Total Assets | $279,174,978 |
| Trust Account Balance | $277,775,824 |
| Cash (Outside Trust) | $1,109,625 |
| Net Income | $1,574,054 |
| Operating Expenses (G&A) | $210,253 |
| Interest Income (Trust Account) | $1,775,824 |
| Total Liabilities | $9,747,652 |
| Deferred Underwriting Fee | $9,660,000 |
| Working Capital | $1,213,092 |
| Shares Outstanding (Public) | 27,600,000 (Subject to redemption) |
| Shares Outstanding (Founder/Private) | 7,662,000 |
Material Changes vs. Prior Period
- Balance Sheet Transformation: Total assets increased from $182,090 at December 31, 2025, to $279,174,978 at March 31, 2026, driven by the IPO proceeds deposited into the Trust Account.
- Revenue Generation: The company generated no operating revenue. Net income of $1,574,054 was derived entirely from interest earned on the Trust Account ($1,775,824) and bank cash ($8,483), offset by G&A expenses.
- Liabilities: Total liabilities increased from $226,611 to $9,747,652, primarily due to the recording of a $9,660,000 deferred underwriting fee payable upon completion of a business combination.
- Equity Structure: The company moved from a small shareholders' deficit to a significant temporary equity classification ($277,775,824) for public shares subject to redemption.
Outlook, Risks, and Management Commentary
- Business Combination Timeline: The company has 24 months from the IPO closing (January 26, 2026) to complete a business combination. If unsuccessful, the company will liquidate and redeem public shares.
- Liquidity: Management believes current cash outside the Trust Account ($1.1 million) is sufficient to fund operations for at least one year. The Sponsor may provide working capital loans up to $1.5 million, convertible into units.
- Redemption Rights: Public shareholders may redeem shares for a pro-rata portion of the Trust Account (approx. $10.06 per share as of March 31, 2026) upon a business combination or liquidation.
- Risks: Risks include the inability to complete a business combination, market volatility, geopolitical instability, and the potential for the Sponsor to be liable for third-party claims reducing Trust Account funds below $10.00 per share.
- Warrants: 7,090,500 warrants are outstanding (6.9M Public, 190.5K Private). They become exercisable 30 days after a business combination or 12 months post-IPO, whichever is later, at $11.50 per share.
Investor Verification Checklist
- Trust Account Yield: Verify the interest rate earned on the $277.8M Trust Account to assess the accretion to the redemption value.
- Deferred Underwriting Fee: Confirm the $9.66M deferred fee obligation and its impact on net tangible assets if a business combination is completed.
- Working Capital Sufficiency: Monitor the $1.1M cash balance outside the Trust Account against monthly administrative fees ($20,000) and due diligence costs to ensure no additional dilutive financing is required.
- Redemption Thresholds: Review the specific terms regarding the 15% redemption limit for "groups" of shareholders and the net tangible asset test.
- Founder Share Lock-up: Verify the lock-up period for the 6.9M Founder Shares (6 months post-combination or until share price exceeds $12.00).